Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Daiichi Sankyo, Asubio Pharmaceuticals Merge | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Daiichi Sankyo, Asubio Pharmaceuticals Merge

Asubio's projects will be integrated into the Daiichi Sankyo's global development organization

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Company, Ltd, will merge with its U.S.-based sister company, Asubio Pharmaceuticals, Inc. As a result, Asubio Pharmaceuticals, Inc. projects will be integrated into the Daiichi Sankyo global development organization, led by Mahmoud Ghazzi, MD, PhD.

Asubio Pharmaceuticals’ parent company, Asubio Pharma Co., Ltd, which is based in Japan, will continue to operate as a wholly owned subsidiary of Daiichi Sankyo Co., Ltd., with a focus on discovery research.

Asubio Pharmaceuticals, Inc.’s ongoing clinical trial in patients with acute spinal cord injury, ASBI 603ASCENT Study (SUN13837) has completed enrollment. An analysis and dissemination of the data will be managed by Daiichi Sankyo.

“In line with the Daiichi Sankyo five-year business plan to optimize our business of delivering innovative treatments to patients, consolidating the current Asubio U.S. projects under the company’s overall R&D organization helps us streamline our operations,” said Glenn Gormley, MD, PhD, senior executive officer and global head of R&D, Daiichi Sankyo Company, Ltd., and executive chairman and president, Daiichi Sankyo, Inc.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics